Scientists from the NSU M.D. College will Discuss -Transformational Approaches to Cancer Immunotherapy and Regenerative Medicine

FORT LAUDERDALE/DAVIE, Fla. – Leading faculty members from the Nova Southeastern University (NSU) College of Allopathic Medicine (M.D. College) are scheduled to present their research related to advancing new approaches to cancer immunotherapy and regenerative medicine at the 2018 World Stem Cell Summit (WSCS).

Housed in NSU’s Center for Collaborative Research, the NSU Cell Therapy Institute focuses on advancing new approaches to cancer immunotherapy and regenerative medicine

Housed in NSU’s Center for Collaborative Research, the NSU Cell Therapy Institute focuses on advancing new approaches to cancer immunotherapy and regenerative medicine

 

“We have built a team that is passionately focused on the potential of cell-based therapies to prevent, treat and cure life-threatening and debilitating diseases such as cardiac disease, cancer and macular degeneration,” said Richard Jove, Ph.D., director, NSU Cell Therapy Institute; chair and professor, Department of Biomedical Sciences, NSU M.D. College; and WSCS co-chair. “We look forward to sharing our innovations alongside our international collaborators and learning from colleagues in this rapidly evolving field of research.”

The WSCS is being held on January 22-26 at the Hyatt Regency in Miami. It is the largest interdisciplinary stem cell meeting in the world, featuring more than 250 prominent scientists, business leaders, investors, philanthropists, regulators, policy-makers, economic development officers, patient advocates and experts in law and ethics, presenting the latest scientific discoveries, commercial and innovation opportunities, legal and regulatory solutions, and best practices. The event is expected to attract more than 1,200 attendees from 40 nations.

Representatives from NSU will also be conducting meetings with academic and corporate partners at the WSCS, including a booth on the exhibit floor.

Presentations from NSU Faculty Scientists

Advancing the Exosome Extracellular Vesicle into the Mainstream
Thomas Temple, M.D. – NSU senior vice president, translational research and economic development; executive associate dean for research, NSU M.D. College

Reversing Cancer with Immunotherapies and Exosomes
Richard Jove, Ph.D. – director, NSU Cell Therapy Institute; chair and professor, Department of Biomedical sciences, NSU M.D. College; and WSCS co-chair

Autophagy-Mediated Stem Cell Responses to Inflammation
Vladimir Beljanski, Ph.D. – faculty researcher, NSU Cell Therapy Institute; assistant professor, Department of Biomedical sciences, NSU M.D. College

Developing Novel Immunotherapies for Cancer
Adil Duru, Ph.D., – faculty researcher, NSU Cell Therapy Institute; assistant professor, Department of Biomedical sciences, NSU M.D. College

Cancer-Derived Exosomes: What Can They Tell Us?
Wendy Weston, Ph.D. – faculty researcher, NSU Cell Therapy Institute; assistant professor, Department of Biomedical sciences, NSU M.D. College

Presentations from NSU Visiting Researchers

Natural Killer Cell-Based Immunotherapy of Patients with Hematological Malignancies
Hans-Gustaf Ljunggren, M.D., Ph.D. – visiting researcher from Karolinska Institutet, NSU Cell Therapy Institute; affiliate dean/clinical professor, Department of Medicine, NSU M.D. College

Advancements in Pluripotency
Outi Hovatta, M.D., Ph.D. – visiting researcher from Karolinska Institutet, NSU Cell Therapy Institute; clinical professor, Department of Biomedical Sciences, NSU M.D. College

Engineering the Next Frontier in Cellular Immunotherapy
Evren Alici, M.D., Ph.D. – visiting researcher from Karolinska Institutet, NSU Cell Therapy Institute; professor, Department of Surgery, NSU M.D. College

Regenerative Medicine Entering and Progressing Through the Clinic
Katarina Le Blanc, M.D., Ph.D. – visiting researcher from Karolinska Institutet, NSU Cell Therapy Institute; clinical professor, Department of Biomedical Sciences, NSU M.D. College

Preferred Metabolism to Improve Cell Expansion Protocol
Karl-Henrick Grinnemo, M.D., Ph.D. – visiting researcher from Uppsala University and Karolinska Institutet, NSU Cell Therapy Institute; NSU M.D. College, clinical associate professor, Department of Medicine

“The NSU Cell Therapy Institute is poised to have an important role in immune-oncology and cell-based therapies,” said Bernard Siegel, executive director, Regenerative Medicine Foundation; and founder and co-chair, WSCS. “We are delighted to have Dr. Richard Jove serve again as a Summit co-chair. He is a proven leader and the team of researchers he has put together at NSU is truly world-class.”

The NSU Cell Therapy Institute is housed in the university’s newly opened $100 million, Center for Collaborative Research (CCR), which is one of the largest (215,000 square feet) and most advanced research facilities in Florida. Located on NSU’s Fort Lauderdale/Davie Campus, the CCR is equipped with wet and dry labs; state-of-the-art research equipment, including access to a high-performance computing environment; and other resources, such as Florida LambdaRail, a high-speed broadband service delivery network with connectivity throughout the nation.

 

# # #

About Nova Southeastern University (NSU): Located in beautiful Fort Lauderdale, Florida, NSU is ranked among US News & World Report’s Top 200 National Research Universities and is a dynamic, private research university providing high-quality educational and research programs at the undergraduate, graduate, and first-professional degree levels. Established in 1964, NSU now includes 16 colleges, the 215,000-square-foot Center for Collaborative Research, a private JK-12 grade school, the Mailman Segal Center for Human Development with specialists in Autism, the world-class NSU Art Museum Fort Lauderdale, and the Alvin Sherman Library, Research and Information Technology Center, which is Florida’s largest public library. NSU has campuses in Fort Lauderdale, Fort Myers, Jacksonville, Miami, Miramar, Orlando, Palm Beach, and Tampa, Florida, as well as San Juan, Puerto Rico, while maintaining a presence online globally. Classified as a research university with “high research activity” by the Carnegie Foundation for the Advancement of Teaching, NSU is one of only 50 universities nationwide to also be awarded Carnegie’s Community Engagement Classification, and is also the largest private institution in the United States that meets the U.S. Department of Education’s criteria as a Hispanic-serving Institution. Please visit www.nova.edu for more information about NSU and realizingpotential.nova.edu for more information on the largest fundraising campaign in NSU history

January 4, 2017

Contact Information:
Jeremy Katzman, M.B.A., APR
Director of Public Relations and Marketing Communications
954-262-5408 (office)
954-661-7000 (cell)
[email protected]